科言猫
学术研究的AI总结
首页
文献互助
订阅
我的收藏
科研工具
选题分析
论文总结
专利管理
专利缴费
专利查询
未登录
返回
期刊详情
Helicobacter
IF
4.3
论文数
150
被引数
4185
相关解读
0
订阅
期刊论文
150
相关解读
0
期刊论文
150
发表时间
发表时间
IF
被引数
Antibiotic Resistance of
Helicobacter pylori
in Eastern China: An Updated Multicenter Cross-Sectional Surveillance Study From 2022 to 2025
中国东部地区幽门螺杆菌的抗生素耐药性:2022年至2025年更新的多中心横断面监测研究
Helicobacter
IF
4.3
2026-10-23
0
PRE
AI
Shihan Xu; Yifan Qiu; Jiayue Wang; Chanjuan Wang; Xianzhu Zhou; Huiyun Zhu; Wenbo Zhu; Pei Xie; Liting Shen; Huabing Huang; Xintong Zhao; Hengjun Gao; Zhaoshen Li; Yiqi Du
分享
收藏
Intermediate OLGA / OLGIM Stages as Early Risk Markers for Gastric Cancer: A Systematic Review and Meta‐Analysis
OLGA/OLGIM分期作为胃癌早期风险标志物:一项系统评价和Meta分析
Helicobacter
IF
4.3
2026-10-13
0
OA
AI
Juan Sebastián Frías‐Ordóñez; Sebastián Niño‐Ramírez; Juan Camilo Pérez; Katherine Caita; José Darío Portillo‐Miño; Arnoldo Riquelme Pérez; Lina Otero‐Parra; Hernando Marulanda‐Fernández; Elder Otero‐Ramos; William Otero‐Regino
分享
收藏
Management Strategies for
Helicobacter pylori
—Application of the Stewardship Principles
幽门螺杆菌的管理策略—— stewardship 原则的应用
Helicobacter
IF
4.3
2026-10-13
0
OA
AI
Francis Megraud; Emilie Bessède; Tamara Matysiak‐Budnik
分享
收藏
Efficacy of Standard Triple Therapy With or Without Statin in
Helicobacter pylori
Eradication: A Randomized Double‐Blind Placebo‐Controlled Trial
标准三联疗法联合或不联合他汀类药物根除幽门螺杆菌的疗效:一项随机双盲安慰剂对照试验
Helicobacter
IF
4.3
2026-10-13
0
OA
AI
Chitchai Rattananukrom; Punnaphol Waranophirun; Anupol Panitchote; Suda Vannaprasaht; Tanita Suttichaimongkol; Kookwan Sawadpanich; Apichart Sangchan; Wattana Sukeepaisarnjaroen; Pisaln Mairiang; Witsarut Manasirisuk
分享
收藏
Opportunistic Gastric Cancer Endoscopic Screening Integrated Into Population-Based Colorectal Cancer Screening: A Retrospective Economic Cost-Comparison Study
机会性胃癌内镜筛查整合到基于人群的结直肠癌筛查中的回顾性经济成本比较研究
Helicobacter
IF
4.3
2026-10-05
0
PRE
AI
B. Mourato; P. Pinto; J. Vieira; M. Vidinha; V. Carvalho; N. Pratas; H. Capote; I. Fronteira; R. Dinis; M. Areia
分享
收藏
Beyond
Helicobacter pylori
: Prevalence, Coinfection, and Clinicopathologic Patterns of Non-
Helicobacter pylori Helicobacter
(NHPH) in Human Gastric Biopsies
超越
幽门螺杆菌
:人胃活检中非
幽门螺杆菌螺杆菌
(NHPH)的流行率、混合感染和临床病理模式
Helicobacter
IF
4.3
2026-10-05
0
OA
AI
Daniel Vizenblit; Maya Azrad; Munir Nashashibi; Halim Roshrosh; Yaakov Maman; Avi Peretz
分享
收藏
Epidemiology of
Helicobacter pylori
and Gastric Atrophy in Rural Southwestern Uganda: The ENIGMA Uganda Study
Helicobacter pylori
和胃萎缩的流行病学:乌干达西南部农村地区ENIGMA研究
Helicobacter
IF
4.3
2026-10-05
0
PRE
AI
Yue Huang; Viktoria Knaze; Joseph Mugisha; Anne-Sophie Navionis; Sabina Rinaldi; Gary M. Clifford; Jin Young Park; Robert Newton
分享
收藏
Diagnostic Accuracy of Serum Antibody, Urine Antibody, and Stool Antigen Tests for
Helicobacter pylori
in Japan: A Systematic Review and Meta-Analysis
血清抗体、尿液抗体和粪便抗原检测对日本幽门螺杆菌感染的诊断准确性:系统评价与Meta分析
Helicobacter
IF
4.3
2026-09-28
0
OA
AI
Chikamasa Ichita; Fumiaki Ishibashi; Yasuhiro Hagiwara; Ayaka Takasu; Yuichiro Kemmoto; Ran Li; Chika Kusano; Tianyi Wei; Yutaka Matsuyama; Nobutake Yamamichi; Manami Inoue; Hideki Ishikawa; Takuji Gotoda
分享
收藏
A Decade of Screening and Treating
Helicobacter pylori
Infection Among First-Year High School Students in Kyoto, Japan: Annual Trends in Infection, Consultation, and Eradication Success Rates (2015–2023)
京都日本高中生一年级学生中幽门螺杆菌感染的十年筛查与治疗:2015–2023年感染、咨询及根除成功率的年度趋势
Helicobacter
IF
4.3
2026-09-28
0
OA
AI
Osamu Handa; Kazuhiko Uchiyama; Tomohisa Takagi; Yuji Naito
分享
收藏
Population-Level Trends in Gastric Cancer Mortality and Incidence After Expansion of Japanese National Health Insurance Coverage for
Helicobacter pylori
Eradication: A Descriptive Time-Trend Study
日本国家健康保险扩大幽门螺杆菌根除覆盖范围后,胃癌死亡率和发病率的群体水平趋势:一项描述性时间趋势研究
Helicobacter
IF
4.3
2026-09-09
0
OA
AI
Masahiro Asaka; Tokuma Tanuma; Akiko Kowada; Shouji Matsushima; Kozo Akino
分享
收藏
A Novel
Helicobacter pylori
Test Based on 16S rRNA Isothermal Amplification Point-of-Care Testing of Throat Swab
基于16S rRNA等温扩增的幽门螺杆菌新型快速检测法(咽拭子采样)
Helicobacter
IF
4.3
2026-09-09
0
PRE
AI
Ziyu Liu; Minqing Wu; Yanhong Li; Qiyu Huang; Zhiying Mao; Yong Diao; Huiyong Yang; Yuying Liu; Chuanbo Xie; Zhaoyan Yu
分享
收藏
Bismuth–Amoxicillin–Vonoprazan Triple, Amoxicillin–Vonoprazan Dual, and Clarithromycin-Based Triple Therapies for First-Line Treatment of
Helicobacter pylori
Infection: A Multicenter, Open-Label, Randomized Trial
铋-阿莫西林-沃诺拉赞三联、阿莫西林-沃诺拉赞双联和基于克拉霉素的三联疗法用于幽门螺杆菌感染的一线治疗:一项多中心、开放标签、随机试验
Helicobacter
IF
4.3
2026-09-01
0
PRE
AI
Ping-I Hsu; Ming-Jen Sheu; Chien-Lin Chen; Wei-Yi Lei; Chih-An Shih; Feng-Woei Tsay; Sung-Shuo Kao; Chang-Bih Shie; Pei-Jui Wu; Chao-Hung Kuo; Jyh-Chin Yang; Kuan-Yang Chen; Seng-Kee Chuah; Chia-Long Lee; Hsi-Chang Lee; Wei-Chen Tai; Tzung-Jiun Tsai; John Y. Kao; Deng-Chyang Wu; the Taiwan Acid-related Disease & Microbiota (TARD-M) Consortium
分享
收藏
14-Day Vonoprazan–Minocycline Dual Therapy Versus Bismuth-Containing Quadruple Therapy for
Helicobacter pylori
Rescue Treatment: A Single-Center Randomized Controlled Noninferiority Trial
14天沃诺拉赞–米诺环素双联疗法与铋剂四联疗法用于幽门螺杆菌补救治疗:一项单中心随机对照非劣效性试验
Helicobacter
IF
4.3
2026-09-01
0
OA
AI
Tingting Yang; Ruijuan Xin; Yanhong Deng; Jun Liu; Xue Li; Xiaole Guo; Linke Ma; Xiaoming Su; Yanxia Liu; Chengdong Su; Qian Hao; Rui Mu; Xiaofei Li; Pengda Wang; Yanling Li; Xue Zhang; Qingrui Li; Yuting Wu; Shengjuan Hu
分享
收藏
Local Price and Clarithromycin Resistance Shape the Cost of Vonoprazan Triple Therapy for
Helicobacter pylori
Eradication
局部价格和克拉霉素耐药性影响幽门螺杆菌根除用Vonoprazan三联疗法的成本
Helicobacter
IF
4.3
2026-09-01
0
PRE
AI
Christos Zavos
分享
收藏
School-Based Helicobacter pylori Screening for Adolescents in Japan: Current Status, Challenges, and Implications: A Narrative Review
日本学校为基础的幽门螺杆菌筛查青少年:现状、挑战与启示:一篇叙事性综述
Helicobacter
IF
4.3
2026-08-19
0
PRE
AI
Eisuke Kameoka; Hiroaki Saito; Takuto Hikichi; Jun Nakamura; Tsunetaka Kato; Takumi Yanagita; Mitsuru Otsuka; Masao Kobayakawa; Masaharu Tsubokura; Hiromasa Ohira
分享
收藏
High Potency Proton Pump Inhibitor Versus Vonoprazan in Helicobacter pylori Triple Therapy
高活性质子泵抑制剂与沃诺拉赞在幽门螺杆菌三联疗法中的比较
Helicobacter
IF
4.3
2026-08-18
0
PRE
AI
Mimi C. Tan; Robert L. Atmar; David Y. Graham
分享
收藏
Efficacy and Safety of Fexuprazan-Based Modified High-Dose Dual Therapy for Helicobacter pylori Eradication: A Randomized Clinical Trial
呋昔拉韦为基础的改良高剂量双重疗法对幽门螺杆菌根除的疗效与安全性:一项随机临床试验
Helicobacter
IF
4.3
2026-08-18
0
OA
AI
Ji Yong Ahn; Ki-Nam Shim; Jung-Ho Park; Sang Gyun Kim; Jeong Hwan Kim; Jeong Seop Moon; Young Hoon Youn; Jae J Kim
分享
收藏
Active Helicobacter pylori Infection and Survival Outcomes in De Novo Metastatic Colorectal Cancer: A Retrospective Cohort Study
幽门螺杆菌活动性感染与原发转移性结直肠癌患者生存结局的关系:一项回顾性队列研究
Helicobacter
IF
4.3
2026-08-18
0
OA
AI
Sait Kitapli; Ali Alkan; Ozgur Tanriverdi
分享
收藏
Diagnostic Value of the Pylori DuoTect Test for Helicobacter pylori Detection in the Vietnamese Population
幽门螺杆菌 DuoTect 检测在越南人群中诊断幽门螺杆菌的价值
Helicobacter
IF
4.3
2026-08-18
0
PRE
AI
Hang Dao Viet; Binh Nguyen Phuc; Thao Dang Thi; Trang Nguyen Thi Huyen; Thuong Nguyen Thu; Uyen Vu Thi Thu; Long Hoang Bao; Long Dao Van
分享
收藏
Antimicrobial Resistance Profile of Helicobacter pylori in Shenzhen, China: A Retrospective Study From 2021 to 2024
深圳市幽门螺杆菌的抗菌药物耐药谱:2021年至2024年的一项回顾性研究
Helicobacter
IF
4.3
2026-08-18
0
PRE
AI
Fan Wu; Ye Chen; Chenghai Yang
分享
收藏